Loading
PP
Portola Pharmaceuticals Inc Stock: price and insider trades · United States
Portola Pharmaceuticals Inc: what insiders have been doing
Only a handful of insider records exist for Portola Pharmaceuticals Inc, the last one from 29 January 2016, too few to describe a trend. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
RevenueUS$101M
Net income-US$251.6M-249.2% margin
Last declaration on 29 January 2016
Declarations4 total
10,000 sharesCommon StockSEC:0001209191-16-094208:0
13,750 sharesCommon StockSEC:0001209191-16-094212:0
28,125 sharesCommon StockSEC:0001209191-16-094215:0
4 of 4 declarations
About Portola Pharmaceuticals Inc
Portola Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for thromboembolic diseases. It is listed on NASDAQ under the ticker PTLA.
